Company registration number 14278488 (England and Wales)
WORLD BIO MARKETS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
WORLD BIO MARKETS LIMITED
COMPANY INFORMATION
Directors
Mr P MacDonald
Mr T Duckworth
Company number
14278488
Registered office
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
Accountants
Ormerod Rutter Limited
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
WORLD BIO MARKETS LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2
Notes to the financial statements
3 - 6
WORLD BIO MARKETS LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF WORLD BIO MARKETS LIMITED FOR THE PERIOD ENDED 31 DECEMBER 2024
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of World Bio Markets Limited for the period ended 31 December 2024 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of World Bio Markets Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of World Bio Markets Limited and state those matters that we have agreed to state to the board of directors of World Bio Markets Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than World Bio Markets Limited and its board of directors as a body, for our work or for this report.

It is your duty to ensure that World Bio Markets Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of World Bio Markets Limited. You consider that World Bio Markets Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of World Bio Markets Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Ormerod Rutter Limited
24 September 2025
Chartered Accountants
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
WORLD BIO MARKETS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 2 -
31 December 2024
31 March 2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,562
1,350
Current assets
Debtors
5
248,811
105,782
Cash at bank and in hand
67,801
112,603
316,612
218,385
Creditors: amounts falling due within one year
6
(392,925)
(235,764)
Net current liabilities
(76,313)
(17,379)
Net liabilities
(74,751)
(16,029)
Capital and reserves
Called up share capital
7
100
100
Profit and loss reserves
(74,851)
(16,129)
Total equity
(74,751)
(16,029)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 24 September 2025 and are signed on its behalf by:
Mr T  Duckworth
Director
Company registration number 14278488 (England and Wales)
WORLD BIO MARKETS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information

World Bio Markets Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Oakley, Kidderminster Road, Droitwich, Worcestershire, WR9 9AY.

1.1
Reporting period

During the period, the company shortened its accounting reference date from 31 March 2025 to 31 December 2024.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

These financial statements have been drawn up on the going concern basis. If the going concern basis were not appropriate, adjustments would have been made to reduce assets to recoverable amounts, to provide for any further liabilities that might arise, and to re-classify fixed assets as current assets and long term liabilities as current liabilities.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the provision of services is recognised by reference to the stage of completion, when the costs incurred and costs to complete can be estimated reliably.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
33% on cost
1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

WORLD BIO MARKETS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

WORLD BIO MARKETS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 5 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2024
2024
Number
Number
Total
5
5
4
Tangible fixed assets
Computer equipment
£
Cost
At 1 April 2024
1,389
Additions
621
At 31 December 2024
2,010
Depreciation and impairment
At 1 April 2024
39
Depreciation charged in the period
409
At 31 December 2024
448
Carrying amount
At 31 December 2024
1,562
At 31 March 2024
1,350
WORLD BIO MARKETS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 6 -
5
Debtors
2024
2024
Amounts falling due within one year:
£
£
Trade debtors
246,056
100,675
Other debtors
2,755
5,107
248,811
105,782
6
Creditors: amounts falling due within one year
2024
2024
£
£
Trade creditors
15,397
22,924
Taxation and social security
2,999
30,457
Other creditors
374,529
182,383
392,925
235,764
7
Called up share capital
2024
2024
2024
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
100
100
100
100
8
Ultimate controlling party

The ultimate controlling party is Mr T Duckworth.

2024-12-312024-04-01falsefalsefalse24 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr P MacDonaldMr T Duckworth142784882024-04-012024-12-3114278488bus:Director12024-04-012024-12-3114278488bus:Director22024-04-012024-12-3114278488bus:RegisteredOffice2024-04-012024-12-31142784882024-12-31142784882024-03-3114278488core:ComputerEquipment2024-12-3114278488core:ComputerEquipment2024-03-3114278488core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3114278488core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3114278488core:CurrentFinancialInstruments2024-12-3114278488core:CurrentFinancialInstruments2024-03-3114278488core:ShareCapital2024-12-3114278488core:ShareCapital2024-03-3114278488core:RetainedEarningsAccumulatedLosses2024-12-3114278488core:RetainedEarningsAccumulatedLosses2024-03-3114278488core:ShareCapitalOrdinaryShareClass12024-12-3114278488core:ShareCapitalOrdinaryShareClass12024-03-3114278488core:ComputerEquipment2024-04-012024-12-31142784882023-04-012024-03-3114278488core:ComputerEquipment2024-03-3114278488core:WithinOneYear2024-12-3114278488core:WithinOneYear2024-03-3114278488bus:OrdinaryShareClass12024-04-012024-12-3114278488bus:OrdinaryShareClass12024-12-3114278488bus:OrdinaryShareClass12024-03-3114278488bus:PrivateLimitedCompanyLtd2024-04-012024-12-3114278488bus:FRS1022024-04-012024-12-3114278488bus:AuditExemptWithAccountantsReport2024-04-012024-12-3114278488bus:SmallCompaniesRegimeForAccounts2024-04-012024-12-3114278488bus:FullAccounts2024-04-012024-12-31xbrli:purexbrli:sharesiso4217:GBP